Objective: To compare a simultaneous versus sequential approach to residual post chemotherapy mass resections in metastatic testis cancer.
Methods: A retrospective review was performed of patients who underwent retroperitoneal and thoracic/cervical resection of post chemotherapy residual masses between 2002 and 2018. Group 1- “Simultaneous” (Combined Retroperitoneal and Thoracic/Cervical resections on the same date); Group 2: “Sequential” (Retroperitoneal and Thoracic/Cervical resections at separate dates).
Results: During the study period, 35 simultaneous and 17 sequential resections were performed. The median age at surgery was 28 years (Range 16-61). The median follow-up from last surgical procedure was 62.7 months (Range 0.4-194). Histology revealed teratoma in 38 (73.1%) patients, necrosis in 8 (15.4%) and viable tumor in 6 (11.5%). Discordant pathology findings between thoracic/cervical and abdominal resections were noted in 16 (30.8%) patients. No differences were observed between the simultaneous vs. sequential groups in median operating time (585 mins vs. 545 mins, p=0.64), blood loss (1300 vs. 1300 mls, p=0.42), or length of stay (9 vs. 11 days, p=0.14). There was no difference between the 5-year (65.7% vs 68.6%) relapse-free survival between the two groups (p= 0.84) or the 5-year (88.6% vs. 100%) overall and disease-specific survival (p=0.25).
Conclusion: Simultaneous resection of retroperitoneal and thoracic/cervical post chemotherapy metastases is a feasible in some patients. It requires multidisciplinary collaboration and a longer primary procedure.